This site is intended for healthcare professionals only

Biomarkers allow early detection of pre-eclampsia

Written by: | Published:

Measuring biomarkers can assess a pregnant woman's Measuring biomarkers can assess a pregnant woman's pre-eclampsia risk

Measuring blood levels of two biomarkers - asymmetric dimethylarginine (ADMA) and homocysteine - might detect women at high risk of developing pre-eclampsia.

The authors measured levels of ADMA, homocysteine, vitamins B6, B12, and folic acid every month from 20 weeks or less of gestation until delivery in 252 women. ADMA inhibits nitric oxide synthase. This enzyme generates nitric oxide, which protects the vascular system. Homocysteine protects against free radicals and endothelial damage.

Please login or register to read the rest of the article and to have access to downloads and comments.

What do you think? Leave a comment below or tweet your views to @IndyNurseMag

This material is protected by MA Healthcare Ltd copyright.
See Terms and Conditions.

Read a free issue from Practice Nursing

Register to read a free issue from our sister publication, Practice Nursing.

Including articles on asthma, diabetes and more. Read your copy.


Sign up to the newsletter


Independent Nurse is the professional resource for primary care and community nurses, providing clinical articles for practice nurses and prescribers.


Subscribe to our newsletter and stay up to date with the latest nursing news.

Stay Connected

Stay social with Independent Nurse by following us on Twitter, liking us on Facebook or connecting on LinkedIn.


Need access to some of our older articles? You can view our archive, or alternatively contact us.

Contact Us

MA Healthcare Ltd.
St Jude's Church, Dulwich Road
London, SE24 0PB

Tel: +44 (0)20 7738 5454
Registered in England and Wales No. 01878373

Meet the team


Find out how to contribute to Independent Nurse here.